Category: Real-World Data

Future Trends in Pharmacoepidemiology: Insights from the 2025 ISPE Conference

Explore the Three C’s of Real-World Evidence Solutions in Today’s Drug Development Landscape

REMS programs explained: A guide for sponsors

A New Look for Evidera and CorEvitas Solutions

Inflation Reduction Act Pipeline Considerations for Drug Developers

Overcoming Orphan Drug Development Challenges with Real-World Data and Evidence

Empowering Patients: The Impact of Lay Patient Perspectives in Clinical Trial Design

Navigating the Challenges and Opportunities of the PICO Framework in the New EU HTA Regulation

Five Predictions for the Biopharma and Biotech Industries in 2024